4
Changes in Ownership
InMed Pharmaceuticals Inc. Filed Acc 0001213900-22-080983
Options or other derivatives
- Chief Operating Officer acquired 7,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| WOUDENBERG MICHAEL Chief Operating Officer | 2022-12-16 | Grant or award · Employee Stock Option (Right to Buy) | +7,500 | 11,342 | D | ||
Loading xslF345X03/ownership.xml…